For Immediate Release
November 5, 2021
The United States—through the United States Agency for International Development—is providing $4 million in additional COVID-19 assistance for Libya. This new funding will provide technical assistance, equipment, and supplies to support Libya’s National Vaccine and Deployment plan and mitigate the spread of COVID-19.
“We are pleased to be able to work in partnership with the Libyan government and Libyan people to respond to this unprecedented global pandemic and strengthen the response capacities needed to forestall or mitigate future crises.” USAID Mission Director John Pennell.
This additional assistance from the historic American Rescue Plan brings the U.S. contribution to combat COVID-19 in Libya to more than $20 million from regular and supplemental appropriations since the start of the pandemic. This assistance has supported the Libyan government and civil society to respond to immediate public health needs, provide emergency assistance to Libya’s most vulnerable communities, and support Libya’s economic recovery.
These efforts build on longstanding U.S. commitment to work in partnership with countries around the globe to tackle global health crises. Over the past 60 years, the U.S. has provided billions of dollars in foreign assistance across the globe to combat diseases such as Ebola, HIV/AIDS, tuberculosis, malaria, and now COVID-19.
The U.S. remains committed to partnering with Libya to end the COVID-19 pandemic, respond to its social and economic impacts, and build back a world that is even better prepared for future health emergencies.